Description

Ultima-Retatrutide, 5 mg

Ultima-Retatrutide 5 mg contains retatrutide, an investigational peptide designed to activate three metabolic hormone receptors: GLP-1, GIP, and glucagon receptors. This triple-agonist activity has made retatrutide particularly interesting in research involving body-weight management, appetite regulation, fat metabolism, glucose control, and metabolic health.

How it works

Retatrutide combines activity at GLP-1, GIP, and glucagon receptors, creating a broader metabolic effect than single- or dual-receptor agonists.

GLP-1 and GIP signaling can influence appetite, food intake, insulin secretion, and glucose regulation, while glucagon receptor activity is associated with energy expenditure and lipid metabolism.

This combination is being studied for its potential to support substantial body-weight reduction and improvements in metabolic parameters, making it especially relevant to fat-loss and body-composition research.

Proper Use and Dosage

The listed product contains 5 mg of retatrutide per vial.

Clinical trials have evaluated once-weekly subcutaneous administration, with doses gradually increased during the treatment period. In a Phase 2 obesity trial, participants received weekly doses ranging from 1 mg to 12 mg, with dose escalation used to improve tolerability.

For a 5 mg presentation:

• 1 mg = 5 administrations per vial
• 2 mg = 2.5 administrations per vial
• 2.5 mg = 2 administrations per vial
• 5 mg = 1 full vial

The 5 mg presentation provides a convenient amount for protocols using lower weekly doses.

Benefits

Ultima-Retatrutide is particularly suited to research involving fat loss, appetite regulation, metabolic health, and body composition.

Key benefits and areas of interest include:

• Supports appetite-regulation research
• Promotes research into body-weight reduction
• Activates GLP-1, GIP, and glucagon receptors
• Supports research into glucose metabolism
• Investigated for increased energy expenditure
• Supports research into fat metabolism
• May support reductions in body fat
• Investigated for improvements in metabolic health
• Particularly interesting for obesity and body-composition research
• Convenient 5 mg presentation

Its unique triple-receptor activity is what makes retatrutide particularly interesting in next-generation metabolic and body-composition research.

Side Effects

Clinical trials have most commonly reported nausea, diarrhea, vomiting, constipation, decreased appetite, and other gastrointestinal effects. These effects have generally been more noticeable during dose escalation.

Where to buy 

Whenever bodybuilders want to buy steroids online, it’s always expected that the steroids shop they buy from – Finest Gears, for example – has the products they desire. And luckily, Finest Gears has Ultima-Retatrutide, 5 mg in stock.